100 related articles for article (PubMed ID: 30851173)
1. Cirrhosis risk score of the donor organ predicts early fibrosis progression after liver transplantation.
Zimmermann A; Darstein F; Hoppe-Lotichius M; Toenges G; Lautem A; Abel F; Schad A; Mittler J; Vollmar J; Grimm D; Lang H; Galle PR; Zimmermann T; Schuppan D
J Gastrointestin Liver Dis; 2019 Mar; 28(1):53-61. PubMed ID: 30851173
[TBL] [Abstract][Full Text] [Related]
2. A 7-gene signature of the recipient predicts the progression of fibrosis after liver transplantation for hepatitis C virus infection.
do O NT; Eurich D; Schmitz P; Schmeding M; Heidenhain C; Bahra M; Trautwein C; Neuhaus P; Neumann UP; Wasmuth HE
Liver Transpl; 2012 Mar; 18(3):298-304. PubMed ID: 22139994
[TBL] [Abstract][Full Text] [Related]
3. Advancing donor liver age and rapid fibrosis progression following transplantation for hepatitis C.
Wali M; Harrison RF; Gow PJ; Mutimer D
Gut; 2002 Aug; 51(2):248-52. PubMed ID: 12117889
[TBL] [Abstract][Full Text] [Related]
4. The recipient CYP2D6 allele 4-associated poor metabolizer status correlates with an early fibrosis development after liver transplantation.
Zimmermann T; Hoppe-Lotichius M; Körner A; Lautem A; Heise M; Foltys D; Weiler N; Biesterfeld S; Schmidtmann I; Galle PR; Otto G; Schuchmann M
Transpl Int; 2011 Nov; 24(11):1059-67. PubMed ID: 21797939
[TBL] [Abstract][Full Text] [Related]
5. Transforming growth factor β1 polymorphisms and progression of graft fibrosis after liver transplantation for hepatitis C virus--induced liver disease.
Eurich D; Bahra M; Boas-Knoop S; Lock JF; Golembus J; Neuhaus R; Neuhaus P; Neumann UP
Liver Transpl; 2011 Mar; 17(3):279-88. PubMed ID: 21384510
[TBL] [Abstract][Full Text] [Related]
6. The histological assessment of liver fibrosis in grafts from extended criteria donors predicts the outcome after liver transplantation: A retrospective study.
D'Errico A; Riefolo M; Serenari M; De Pace V; Santandrea G; Monica M; de Cillia C; Ravaioli M; Cescon M; Vasuri F;
Dig Liver Dis; 2020 Feb; 52(2):185-189. PubMed ID: 31155489
[TBL] [Abstract][Full Text] [Related]
7. A seven-gene signature (cirrhosis risk score) predicts liver fibrosis progression in patients with initially mild chronic hepatitis C.
Marcolongo M; Young B; Dal Pero F; Fattovich G; Peraro L; Guido M; Sebastiani G; Palù G; Alberti A
Hepatology; 2009 Oct; 50(4):1038-44. PubMed ID: 19676127
[TBL] [Abstract][Full Text] [Related]
8. Liver transplantation for HCV cirrhosis: improved survival in recent years and increased severity of recurrent disease in female recipients: results of a long term retrospective study.
Belli LS; Burroughs AK; Burra P; Alberti AB; Samonakis D; Cammà C; De Carlis L; Minola E; Quaglia A; Zavaglia C; Vangeli M; Patch D; Dhillon A; Cillo U; Guido M; Fagiuoli S; Giacomoni A; Slim OA; Airoldi A; Boninsegna S; Davidson BR; Rolles K; Pinzello G
Liver Transpl; 2007 May; 13(5):733-40. PubMed ID: 17370330
[TBL] [Abstract][Full Text] [Related]
9. Impact of Donor and Recipient Single Nucleotide Polymorphisms in Living Liver Donor Transplantation for Hepatitis C.
Miyaaki H; Ichikawa T; Taura N; Miuma S; Honda T; Shibata H; Soyama A; Hidaka M; Takatsuki M; Eguchi S; Nakao K
Transplant Proc; 2015 Dec; 47(10):2916-9. PubMed ID: 26707313
[TBL] [Abstract][Full Text] [Related]
10. Role of a cirrhosis risk score for the early prediction of fibrosis progression in hepatitis C patients with minimal liver disease.
Trépo E; Potthoff A; Pradat P; Bakshi R; Young B; Lagier R; Moreno C; Verset L; Cross R; Degré D; Lemmers A; Gustot T; Berthillon P; Rosenberg W; Trépo C; Sninsky J; Adler M; Wedemeyer H
J Hepatol; 2011 Jul; 55(1):38-44. PubMed ID: 21145859
[TBL] [Abstract][Full Text] [Related]
11. Donor-specific alloantibodies are associated with fibrosis progression after liver transplantation in hepatitis C virus-infected patients.
O'Leary JG; Kaneku H; Jennings L; Susskind BM; Terasaki PI; Klintmalm GB
Liver Transpl; 2014 Jun; 20(6):655-63. PubMed ID: 24678017
[TBL] [Abstract][Full Text] [Related]
12. One-year protocol liver biopsy can stratify fibrosis progression in liver transplant recipients with recurrent hepatitis C infection.
Firpi RJ; Abdelmalek MF; Soldevila-Pico C; Cabrera R; Shuster JJ; Theriaque D; Reed AI; Hemming AW; Liu C; Crawford JM; Nelson DR
Liver Transpl; 2004 Oct; 10(10):1240-7. PubMed ID: 15376304
[TBL] [Abstract][Full Text] [Related]
13. Aspirin may reduce liver fibrosis progression: Evidence from a multicenter retrospective study of recurrent hepatitis C after liver transplantation.
Poujol-Robert A; Boëlle PY; Conti F; Durand F; Duvoux C; Wendum D; Paradis V; Mackiewicz V; Chazouillères O; Corpechot C; Poupon R
Clin Res Hepatol Gastroenterol; 2014 Oct; 38(5):570-6. PubMed ID: 25130796
[TBL] [Abstract][Full Text] [Related]
14. Donor IFNL4 Genotype Is Associated with Early Post-Transplant Fibrosis in Recipients with Hepatitis C.
Aiken T; Garber A; Thomas D; Hamon N; Lopez R; Konjeti R; McCullough A; Zein N; Fung J; Askar M; John BV
PLoS One; 2016; 11(11):e0166998. PubMed ID: 27875564
[TBL] [Abstract][Full Text] [Related]
15. Donor Age Still Matters in Liver Transplant: Results From the United Network for Organ Sharing-Scientific Registry of Transplant Recipients Database.
Montenovo MI; Hansen RN; Dick AAS; Reyes J
Exp Clin Transplant; 2017 Oct; 15(5):536-541. PubMed ID: 27759559
[TBL] [Abstract][Full Text] [Related]
16. Explanted liver inflammatory grade predicts fibrosis progression in hepatitis C recurrence.
Ghabril M; Dickson RC; Krishna M; Machicao V; Aranda-Michel J; Bonatti H; Nguyen JH
Liver Transpl; 2011 Jun; 17(6):685-94. PubMed ID: 21618689
[TBL] [Abstract][Full Text] [Related]
17. Identifying the superior measure of rapid fibrosis for predicting premature cirrhosis after liver transplantation for hepatitis C.
Howell J; Sawhney R; Angus P; Fink M; Jones R; Wang BZ; Visvanathan K; Crowley P; Gow P
Transpl Infect Dis; 2013 Dec; 15(6):588-99. PubMed ID: 24028328
[TBL] [Abstract][Full Text] [Related]
18. Liver transplantation of hepatitis B surface antigen positive donors to hepatitis B core antibody recipients: analysis of 27 patients.
Krishnamoorthi R; Manickam P; Cappell MS
Minerva Gastroenterol Dietol; 2014 Jun; 60(2):113-8. PubMed ID: 24780945
[TBL] [Abstract][Full Text] [Related]
19. Use of hepatitis C virus-positive grafts in liver transplantation: a single-centre experience.
Ricchiuti A; Brunati A; Mirabella S; Pierini A; Franchello A; Salizzoni M
Transplant Proc; 2005; 37(6):2569-70. PubMed ID: 16182746
[TBL] [Abstract][Full Text] [Related]
20. YKL-40-gene polymorphism affects acute cellular rejection and fibrosis progression after transplantation for hepatitis C virus-induced liver disease.
Eurich D; Neumann UP; Boas-Knoop S; Neuhaus R; Kiessling A; Yahyazadeh A; Trautwein C; Wasmuth H; Puhl G; Neuhaus P; Bahra M
J Gastroenterol Hepatol; 2013 Jan; 28(1):153-60. PubMed ID: 22989351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
